Imetelstat Combination Therapy

A Phase 1 Study of GRN163L (Imetelstat) in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia That is in Second or Greater Relapse or That is Refractory to Relapse Therapy; Myelodysplastic Syndrome or Juvenile Myelomonocytic Leukemia in First or Greater Relapse or is Refractory to Relapse Therapy

Near Add Your Location

Sorting 19 by

Alvin J. Siteman Cancer Center
Washington University Medical Campus
St. Louis, MO
  • Accepting patients

Center of Excellence

University of Minnesota - Masonic Cancer Center
Minneapolis, MN
  • Accepting patients
Riley Hospital for Children
Indiana University Health
Indianapolis, IN
  • Accepting patients
Children's Hospital of Philadelphia
Philadelphia, PA
  • Accepting patients
Morgan Stanley Children's Hospital
CUIMC/NewYork-Presbyterian
Manhattan, NY
  • Accepting patients
C S Mott Children's Hospital
University of Michigan
Ann Arbor, MI
  • Accepting patients
Children's of Alabama
Birmingham, AL
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 803-1766

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.